NYSE American - Nasdaq Real Time Price USD

Milestone Scientific Inc. (MLSS)

0.3097 +0.0077 (+2.55%)

As of 11:54:25 AM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures

GlobeNewswire 12d ago

MLSS
+2.55%
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

GlobeNewswire 1mo ago

MLSS
+2.55%
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

GlobeNewswire 1mo ago

MLSS
+2.55%
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

GlobeNewswire 2mo ago

MLSS
+2.55%
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

GlobeNewswire 3mo ago

MLSS
+2.55%
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

GlobeNewswire 3mo ago

MLSS
+2.55%
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

GlobeNewswire 3mo ago

MLSS
+2.55%
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

GlobeNewswire 4mo ago

MLSS
+2.55%
Milestone Scientific Strengthens Board to Support Next Phase of Growth

GlobeNewswire 4mo ago

MLSS
+2.55%
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

GlobeNewswire 5mo ago

MLSS
+2.55%
Milestone Scientific Inc. Completes $2.15 Million Private Placement

GlobeNewswire 6mo ago

MLSS
+2.55%
Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

GlobeNewswire 7mo ago

MLSS
+2.55%

Performance Overview

Return	MLSS	S&P 500 (^GSPC)
YTD	+11.63%	+9.81%
1-Year	-20.68%	+10.02%
3-Year	-60.34%	+70.25%

U.S. markets close in 3h 28m

Milestone Scientific Inc. (MLSS)

Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

Milestone Scientific Strengthens Board to Support Next Phase of Growth

Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025